Nephros (NASDAQ:NEPH) Shares Down 1.3% – What’s Next?

Shares of Nephros, Inc. (NASDAQ:NEPH) fell 1.3% on Monday . The stock traded as low as $1.55 and last traded at $1.56. 2,626 shares changed hands during trading, a decline of 83% from the average session volume of 15,813 shares. The stock had previously closed at $1.58.

Nephros Trading Down 0.7 %

The firm has a market cap of $15.71 million, a PE ratio of -10.71 and a beta of 1.18. The company has a 50-day simple moving average of $1.85 and a 200 day simple moving average of $2.05.

Nephros (NASDAQ:NEPH) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.02). Nephros had a negative net margin of 9.40% and a negative return on equity of 15.64%. The firm had revenue of $3.25 million for the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Nephros stock. Dimensional Fund Advisors LP purchased a new stake in Nephros, Inc. (NASDAQ:NEPH) during the second quarter, according to its most recent disclosure with the SEC. The firm purchased 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned approximately 0.17% of Nephros at the end of the most recent quarter. Institutional investors own 41.10% of the company’s stock.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.